TABLE 3.
Characteristics of clinical variables in those with high- and low-G″ values among patients with F0–2
| G″ <0.402 | G″ ≥0.402 | p-value | |
|---|---|---|---|
| n = 6 | n = 15 | ||
| Sex, male | 3 (50) | 12 (80) | 0.29 |
| Age (years) | 63 [52–66] | 66 [48–71] | 0.79 |
| BMI (kg/m2) | 23.5 [23.3–24.6] | 27.7 [25.2–32.7] | 0.02 |
| Albumin (g/dl) | 4.6 [4.5–5.0] | 4.4 [4.3–4.7] | 0.34 |
| Total bilirubin (mg/dl) | 1.0 [0.6–1.2] | 0.8 [0.6–0.9] | 0.48 |
| γ-GTP (U/L) | 51 [30–82] | 63 [32–81] | 0.87 |
| AST (U/L) | 44 [20–60] | 54 [39–66] | 0.25 |
| ALT (U/L) | 80 [32–131] | 63 [48–117] | 0.90 |
| FIB-4 | 1.06 [0.78–1.33] | 1.91 [1.54–2.82] | 0.01 |
| Ferritin (ng/ml) | 155 [114–219] | 354 [143–494] | 0.17 |
| Platelets (103/mm3) | 259 [252–280] | 188 [167–198] | 0.01 |
| PT-INR | 0.92 [0.90–0.96] | 1.00 [0.97–1.05] | 0.02 |
| M2BPGi | 0.50 [0.44–0.64] | 0.78 [0.70–0.92] | 0.06 |
| Type IV collagen 7s (ng/ml) | 4.2 [4.0–5.0] | 5.6 [5.0–6.4] | 0.06 |
| PDFF (%) | 21.7 [10.0–30.8] | 14.5 [8.4–20.9] | 0.48 |
| Alcohol (g/day) | 0 [0–5] | 5 [0–5] | 0.58 |
| SS (kPa) | 1.90 [1.77–2.01] | 2.53 [2.29–2.95] | 0.01 |
| Brunt stage | 1 [0–1] | 2 [0–2] | 0.03 |
Note: Data are expressed as n (%) or median [IQR].
Abbreviations: BMI, body mass index; FIB-4, Fibrosis-4 index; γ-GTP, gamma-glutamyl transpeptidase; PDFF, proton density fat fraction; PT-INR, prothrombin time-international normalized ratio; SS, shear stiffness.